Verrica Pharmaceuticals Inc

VRCA

Company Profile

  • Business description

    Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

  • Contact

    44 West Gay Street
    Suite 400
    West ChesterPA19380
    USA

    T: +1 484 453-3300

    E: [email protected]

    https://www.verrica.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    71

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,820.306.40-0.07%
CAC 407,828.7873.47-0.93%
DAX 4024,265.12191.69-0.78%
Dow JONES (US)44,416.92233.72-0.52%
FTSE 1008,940.9134.75-0.39%
HKSE24,139.57111.200.46%
NASDAQ20,625.934.74-0.02%
Nikkei 22539,569.6876.68-0.19%
NZX 50 Index12,686.6873.52-0.58%
S&P 5006,262.0518.41-0.29%
S&P/ASX 2008,580.109.10-0.11%
SSE Composite Index3,510.180.500.01%

Market Movers